5 Followers on Owler

Palleon

is a biotechnology company that develops and commercializes glyco-immune checkpoint inhibitors for the treatment of cancer... Read more

is a biotechnology company that develops and commercializes glyco-immune checkpoint inhibitors for the treatment of cancer... Read more

Founder & CEO

Jim Broderick

CEO Approval Rating

88/100

2015

PrivateIndependent Company

Est. Annual Revenue

$5.0-25M

Agree?

Est. Employees

25-100

Agree?

Trending Companies